BioMarin Receives Orphan Drug Designation from FDA for Pompe Disease
Posted on: August 30, 2010 - Filed under
Excerpt from August 30, 2010 press release . . .
The Official Website of the Acid Maltase Deficiency Association
It is difficult to say what is impossible for the dreams of yesterday are the hopes of today and the reality of tomorrow. - Robert H. Goddard
Other News
Get Involved
Your generous contribution will go a long way into improving the quality of life of Pompe Disease Patients worldwide.
Recently Added Items
- Alternatives to Organ Donation—Editorial by a Late-Onset Pompe Patient was posted in Editorials, last May 14, 2012
- BioMarin Pompe Program Update was posted in News, last May 14, 2012
- 2011 AMDA/IPA Conference DVDs available! was posted in News, last April 09, 2012
- Needle Core Muscle Biopsy was posted in Webinar, last April 02, 2012
- March 2012 Community Update From Genzyme Regarding 160L Myozyme Supply was posted in News, last March 20, 2012
© 2011 Acid Maltase Deficiency Association
Disclaimer: The AMDA does not endorse any of the products, medications, treatments or information reported herein. The website and its contents is intended for informational purposes, only. We strongly advise that you discuss all medications, treatments, and/or products with your physician.